ProCE Banner Activity

Integrating Bispecific Antibodies Into the Treatment of Patients With R/R FL

Slideset

Learn more about the importance and role of bispecific antibodies in the management of patients with R/R FL.

Released: December 04, 2024

Expiration: December 03, 2025

Share

Faculty

Peter Martin

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC in partnership with Follicular Lymphoma Foundation.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Genmab US, Inc.; and Ipsen Biopharmaceuticals, Inc.

AstraZeneca

Genmab US, Inc.

Ipsen Biopharmaceuticals Inc

Partners

Follicular Lymphoma Foundation

ProCE Banner